Growth Hormone Dynamics and Sleep Regulation

Growth hormone (GH) is secreted in a pulsatile manner under the control of hypothalamic releasing and inhibiting factors, with peak amplitudes closely linked to sleep architecture. The deepest stage of non-rapid eye movement sleep, known as slow-wave sleep (SWS), is the principal window for GH release in both nocturnal and diurnal species. This synchronisation arises from the interplay between circadian pacemakers, homeostatic sleep pressure and endocrine feedback loops involving insulin-like growth factor 1 (IGF-1). Beyond its classical roles in somatic growth and metabolism, GH exerts widespread effects on tissue repair, immune function and cognitive processes, many of which are enhanced by sleep-dependent secretory rhythms. Disruption of sleep quality or architecture—through insomnia, shift work or ageing—diminishes nocturnal GH pulses, with downstream consequences for anabolic balance and cardiovascular health. Conversely, alterations in GH signalling, whether by endogenous deficiency or therapeutic administration, can modulate sleep continuity and depth. Understanding the bidirectional regulation between GH dynamics and sleep offers new avenues for optimising restorative physiology across the lifespan.

Research from Nature Portfolio

Enhancement of SWS using hypnotic suggestions before a 90-minute afternoon nap has been shown to amplify nocturnal-patterned GH release in healthy adults, while concurrently boosting secretion of prolactin and aldosterone. This non-pharmacological intervention shifted autonomic balance towards parasympathetic dominance, reproducing the key endocrine and cardiovascular features of deep sleep. The study highlights potential applications of sleep-depth modulation to harness hormone-mediated restorative processes without direct hormone administration.

Growth Hormone Dynamics and Sleep Regulation publication trend

The graph below shows the total number of articles in growth hormone dynamics and sleep regulation across all publications each year (not limited to Nature Index journals).

Technical terms

Growth Hormone (GH): A peptide hormone produced by the anterior pituitary that stimulates somatic growth, tissue repair and metabolic processes, released in pulses largely during deep sleep.

Insulin-like Growth Factor 1 (IGF-1): A hormone mainly synthesised in the liver in response to GH, mediating many of GH’s anabolic and growth-promoting effects.

Slow-Wave Sleep (SWS): The deepest phase of non-rapid eye movement sleep characterised by high-amplitude, low-frequency brain waves (stage N3) and associated with peak GH secretion.

References

1. Complex relationship between growth hormone and sleep in children: insights, discrepancies, and implications. Frontiers in Endocrinology (2024).
2. Lower serum insulin-like growth factor 1 concentrations in patients with chronic insomnia disorder. Frontiers in Psychiatry (2023).
3. Hypnotic enhancement of slow-wave sleep increases sleep-associated hormone secretion and reduces sympathetic predominance in healthy humans. Communications Biology (2022).
4. Nocturnal Secretory Patterns of FSH, GH, LH and TSH. Upsala Journal of Medical Sciences (1974).